Tag
NSCLC
- Krystal Biotech co‑founder makes Forbes 250 innovators list
- Ohio university awarded almost half a million for lung cancer studies
- Samsung Medical Center develops deep learning model to predict lung cancer recurrence
- Novocure's electric fields device approved for treating lung cancer in Japan
- Kentucky facility now diagnosing lung cancer and performing surgery same day
- Lantern Pharma completes Japanese enrolment for lung cancer drug trial
- Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data
- Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st‑line treatment
- Early lung cancer diagnosis saves 52‑year‑old Indian man's life
- British scientists develop lung cancer blood test that gives results in 40 minutes
- Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds
- Scientists develop scan technique to light up aggressive lung cancer 'like a Christmas tree'
- Immutep starts multinational Phase III lung cancer drug trial at 150 sites
- Novocure scoops FDA approval for electric field lung cancer treatment device